Anixa Biosciences, Inc. (ANIX)
3.48
-0.12
(-3.33%)
USD |
NASDAQ |
Aug 28, 16:00
3.59
+0.11
(+3.16%)
After-Hours: 20:00
Anixa Biosciences Revenue (TTM) : 0.00 for April 30, 2026
Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.00 |
| January 31, 2026 | 0.00 |
| October 31, 2025 | 0.00 |
| July 31, 2025 | 0.00 |
| April 30, 2025 | 0.00 |
| January 31, 2025 | 0.00 |
| October 31, 2024 | 0.00 |
| July 31, 2024 | 0.00 |
| April 30, 2024 | 0.00 |
| January 31, 2024 | 0.21M |
| October 31, 2023 | 0.21M |
| July 31, 2023 | 0.21M |
| April 30, 2023 | 0.21M |
| January 31, 2023 | 0.00 |
| October 31, 2022 | 0.00 |
| July 31, 2022 | 0.00 |
| April 30, 2022 | 0.00 |
| January 31, 2022 | 0.00 |
| October 31, 2021 | 0.5125M |
| July 31, 2021 | 0.5125M |
| April 30, 2021 | 0.5125M |
| January 31, 2021 | 0.5125M |
| October 31, 2020 | 0.00 |
| July 31, 2020 | 0.00 |
| April 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| January 31, 2020 | 0.25M |
| October 31, 2019 | 0.25M |
| July 31, 2019 | 0.25M |
| April 30, 2019 | 0.6125M |
| January 31, 2019 | 1.112M |
| October 31, 2018 | 1.112M |
| July 31, 2018 | 1.112M |
| April 30, 2018 | 1.112M |
| January 31, 2018 | 0.3625M |
| October 31, 2017 | 0.3625M |
| July 31, 2017 | 0.5625M |
| April 30, 2017 | 0.30M |
| January 31, 2017 | 0.30M |
| October 31, 2016 | 0.30M |
| July 31, 2016 | 0.10M |
| April 30, 2016 | 0.095M |
| January 31, 2016 | 0.12M |
| October 31, 2015 | 9.255M |
| July 31, 2015 | 10.63M |
| April 30, 2015 | 11.72M |
| January 31, 2015 | 12.80M |
| October 31, 2014 | 3.667M |
| July 31, 2014 | 2.679M |
| April 30, 2014 | 1.492M |
| January 31, 2014 | 0.3867M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 669.50M |
| Oncolytics Biotech, Inc. | 0.00 |
| Sangamo Therapeutics, Inc. | 34.56M |
| Sarepta Therapeutics, Inc. | 1.974B |
| Vicapsys Life Sciences, Inc. | 0.00 |